Reuters logo
BRIEF-AB Science says that Masitinib has protective effect in Amyotrophic Lateral Sclerosis
January 3, 2017 / 6:17 PM / a year ago

BRIEF-AB Science says that Masitinib has protective effect in Amyotrophic Lateral Sclerosis

Jan 3 (Reuters) - AB Science SA :

* AB Science announces that new preclinical data demonstrate that Masitinib has an unexpected protective effect on muscles and nerves in Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease

* These new data, presented at the 27th International Symposium on ALS/MND, in Ireland, have a robust pharmacological justification to the positive results of the interim analysis of the recently published Phase 3 study Source text for Eikon: [ID: nGNXNNSWEa] Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below